Titan Pharmaceuticals Stock Analysis

Titan Stock Analysis Notes

About 45.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.52. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Titan Pharmaceuticals recorded a loss per share of 6.64. The entity last dividend was issued on the 1st of December 2020. The firm had 1:20 split on the 9th of January 2024. Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. The company was incorporated in 1992 and is based in South San Francisco, California. Titan Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To find out more about Titan Pharmaceuticals contact Gim Seow at 650 244 4990 or learn more at https://www.titanpharm.com.

Titan Pharmaceuticals Investment Alerts

Titan Pharmaceuticals Upcoming and Recent Events

Titan Largest EPS Surprises

View All Earnings Estimates

Titan Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Titan Stock Institutional Investors

Note, although Titan Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Titan Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.34 M.

Titan Profitablity

Management Efficiency

Titan Pharmaceuticals has return on total asset (ROA) of (1.7263) % which means that it has lost $1.7263 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6899) %, meaning that it created substantial loss on money invested by shareholders. Titan Pharmaceuticals' management efficiency ratios could be used to measure how well Titan Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/25/2025, Return On Tangible Assets is likely to drop to -1.69. In addition to that, Return On Capital Employed is likely to drop to -1.96. As of 03/25/2025, Non Current Liabilities Other is likely to grow to about 1 M, while Total Current Liabilities is likely to drop slightly above 458.9 K.

Technical Drivers

As of the 25th of March, Titan Pharmaceuticals has the Coefficient Of Variation of 1255.93, semi deviation of 3.85, and Risk Adjusted Performance of 0.0803. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Titan Pharmaceuticals, as well as the relationship between them.

Titan Pharmaceuticals Price Movement Analysis

Titan Pharmaceuticals Insider Trading Activities

Titan Pharmaceuticals Outstanding Bonds

Titan Pharmaceuticals Predictive Daily Indicators

Titan Pharmaceuticals Corporate Filings

Titan Pharmaceuticals Forecast Models

Titan Pharmaceuticals' time-series forecasting models are one of many Titan Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Titan Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Titan Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Titan shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Titan Pharmaceuticals. By using and applying Titan Stock analysis, traders can create a robust methodology for identifying Titan entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Titan analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Titan analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Titan Pharmaceuticals stock analysis indicators help investors evaluate how Titan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Titan Pharmaceuticals shares will generate the highest return on investment. By understating and applying Titan Pharmaceuticals stock analysis, traders can identify Titan Pharmaceuticals position entry and exit signals to maximize returns.

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.